Sun Pharma receives DCGI approval to manufacture and market generic semaglutide injection in India for chronic weight management
Read More
Sun Pharma Announces the Availability of UNLOXCYT™ (cosibelimab-ipdl) for Advanced Cutaneous Squamous Cell Carcinoma (aCSCC)
Read More
Sun Pharma introduces its global innovative drug, Ilumya® in India for treatment of moderate-to-severe Plaque Psoriasis
Read More
Recent Comments